Q3 2024 Earnings Call Transcript November 9, 2024 Operator: Good afternoon, everyone, and welcome to the Atea Pharmaceuticals Third Quarter 2024 Financial Results and Business Update Conference Call.
Halneuron ® has been granted fast track designation from the Food and Drug Administration (“FDA”) for the treatment of CINP. Next milestone: Interim data from the ongoing Phase 2b CINP study are ...
Kaiser Permanente Northern California’s (KPNC) systematic surveillance and management program for chronic hepatitis B (CHB) has led to marked improvements in patient adherence to imaging ...